LYFE Capital β Full Portfolio
22 tracked investments Β· listed companies and verified rows first
Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system.
BiotechDeep TechSemiconductorsBoston, US
Jeffrey Abbott(Co-Founder & CEO)Vince Wu(Co-Founder & CTO)Duane Sword(Co-Founder & CBO)inDonhee Ham(Scientific Co-Founder)Hongkun Park(Scientific Co-Founder)Vince (Wenxuan) Wu(Founder)in
Co-investorsAnzu PartnersBantam GroupDraper AssociatesBoxOne Ventures
Bora Pharmaceuticals is a pharmaceutical services company offering CDMO (contract development and manufacturing) for both small molecule and large molecule/biologics products, alongside its own drug development focused on specialty pharma and rare diseases.
Advanced ManufacturingBiotechHealthtech
Bobby Sheng(Founder)
New Jersey-based end-to-end data service CRO leveraging Asia to improve operational efficiency.
BiotechCleveland, US
Arnon Chait(Executive Officer, Director)ANDREW SUMMERS(Executive Officer)
BoardNOEL JEE(Director)inJOSEPH RICH(Director)SAMEER ROHATGI(Director)DARA WRIGHT(Director)
Co-investorsJobsOhio VenturesJumpstart VenturesSofinnova Ventures
China-based surgical robotics company with approvals for both multi-port and single-port endoscopy systems.
Singapore-based specialized MedTech contract development and manufacturing organization (CDMO) with a strong foothold in the endoscopic sector.
HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics.
AI & Machine LearningBiotechHealthtech
Liang Schweizer(Founder)in
Co-investorsB Capital GroupB4 CapitalTrinity Innovation Bioventure SingaporeIDG CapitalLegend CapitalSequoia Capital
Imeik develops medical aesthetic products focused on skin and anti-aging treatments.
BiotechHealthtechWellness & Fitness
South Korean energy-based medical aesthetic device company with diversified product lines and fast iteration.
Medical device company in China's minimally invasive surgery market; LYFE Fund I portfolio company taken public.
First-in-class ADC platform partnered with Roche and BioNTech.
Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.
BiotechDeep TechNew MaterialsSan Diego, US
J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)
BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)John Nicols(Director)Todd Peterson(Director)
Co-investors11.2 CapitalDCVC (Data Collective)iSelect FundAlexandriaArgonautic VenturesCasdin Capital+1 more
Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders.
BiotechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)James Stutz(Executive Officer)Arnold Kriegstein(Director)
BoardPeter Svennilson(Director)inTim Kutzkey(Director)Ray Kelleher(Director)
Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+7 more
Noah Medical develops the Galaxy System, a robotic bronchoscopy platform that integrates advanced imaging, precision targeting, and adaptive workflow for real-time lesion localization and lung diagnostics.
HealthtechMedical DevicesRobotics
Co-investors1955 CapitalChina Growth CapitalProsperity7 VenturesShangBay Capital LLC
Nucleix develops liquid biopsy and molecular diagnostic tests for early cancer detection, including its Bladder EpiCheck test for bladder and upper tract urinary cancer and a blood test in development for early-stage lung cancer.
BiotechHealthtechMedical Devices
Co-investorsGefen CapitalOrbiMedRA CapitalBlackRockLilly Asia VenturesSands Capital Ventures
Co-investorsB Capital GroupB4 CapitalLAVLilly Asia VenturesNextech InvestRA Capital
Sciwind Biosciences is a commercial-stage biopharmaceutical company that discovers, develops, and delivers therapeutics focused on metabolic and weight management conditions, serving patients globally.
BiotechHealthtech
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.